Transgenic rats as models for hypertension

Journal of Human Hypertension

Volumn 11, Issue 9, 1997, Pages 577-581

  Pinto Sietsma, S J ^a   Paul, M ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Hypertension; Rat models; Transgenics

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; HYPERTENSION; NONHUMAN; PATHOPHYSIOLOGY; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TRANSGENIC ANIMAL;

EID: 0030714635     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000506     Document Type: Review

References (36)

1. Hasty P, Ramirez SR, Krumlauf R, Bradley A. Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells. Nature 1991; 350: 243-246.
2. Franz WM et al. Transgenic animal models: new avenues in cardiovascular physiology. J Mol Med 1997; 75: 115-129.
3. Lifton RP et al. Archimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoidremecliable aldostronism and human hypertension. Nature 1992; 355: 262-265.
4. Sutherland DJ, Ruse JL, Laidlaw JC. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Cann Med Assoc J 1966; 95: 1109-1119.
5. New MI, Peterson RE. A new form of congenital adrenal hyperplasia. J Clin Endocr Metab 1967; 27: 300-305.
6. Chu MD, Ulick SJ. Isolation and identification of 18-hydroxycortisol from the urine of patients with primary aldostronism. J Biol Chem 1982; 257: 2218-2224.
7. Ulick SJ, Chu MD, Land MJ. Biosynthesis of 18-oxocortisol by aldosterone-producing adrenal tissue. J Biol Chem 1983; 258: 5498-5502.
8. Ulick SJ et al. Defective fasciculata zone function as the mechanism of glucocorticoid-remediable aldostronism. J Clin Endocr Metab 1990; 71: 1151-1157.
9. Shimkets RA et al. Liddles syndrome: heritable human hypertension caused by mutations in the β-subunit of the epithelial sodium channel. Cell 1994; 79: 407-414.
10. Liddle GW, Bledsoe T, Coppage WS. A familial renal disorder simulating primary aldostronism but with negligible aldosterone secretion. Trans Assoc Am Physicians 1963; 76: 199-213.
11. Ward R. Familial aggregation and genetic epidemiology of blood pressure. In: Laragh JH, Brenner BM (eds). Hypertension: Pathophysiology, Diagnosis and Management. Raven Press: New York, 1990, pp 81-100.
12. Lifton RP, Jeunemaitre X. Finding genes that cause human hypertension. J Hypertens 1993; 11: 231-236.
13. Mullins JJ et al. Expression of the DBA/2J Ren-2 gene in the adrenal gland of transgenic mice. EMBO J 1989; 8: 4065-4072.
14. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harboring the mouse Ren-2 gene. Nature 1990; 344: 541-544.
15. Lee MA et al. Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27. Am J Physiol 1996; 270: E919-E929.
16. Hilgers KF et al. Increased vascular angiotensin formation in female rats harboring the mouse REN-2 gene. Hypertension 1992; 19: 687-691.
17. Yamaguchi TZ et al. Zonal distribution and regulation of adrenal renin in a transgenic model of hypertension in the rat. Endocrinology 1992; 131: 1955-1962.
18. Pinto YM et al. Cardiovascular end-organ damage in REN-2 transgenic rats compared to spontaneously hypertensive rats. J Mol Med 1977; 75: 371-377.
19. Buikema H et al. Normalization of endothelial function by quinapril and losartan, but not by carvediol, in hypertensive transgenic (mRen-2)27 rats. Circulation 1996; 94 (8): I-40 (Abstract).
20. Lee MA et al. Differential gene expression of renin and angiotensinogen in the TGR(Ren2)27 transgenic rat. Hypertension 1995; 25: 570-580.
21. Ganten D et al. Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes. Proc Natl Acad Sci USA 1992; 89: 7806-7810.
22. Bohlender J et al. High human hypertension in transgenic rats. Hypertension 1997; 29: 428-434.
23. Tian XL et al. A new transgenic rat model overexpressing human angiotensin-converting enzyme in the heart, Hypertension 1996; 28(3): 520 (Abstract).
24. Yanagisawa M et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 32: 411-415.
25. Gross P et al. Potential role of endothelin in the physiological and pathological regulation of kidney function. Endothelium 1993; 1: 71-83.
26. Hirata Y, Takagi Y, Pukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989; 78: 225-228.
27. Bobik A et al. Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol 1990; 258: C408-C415.
28. Alberts GF et al. Constitutive endothelin-1 over-expression promotes smooth muscle cell proliferation via an external autocrine loop. J Biol Chem 1994: 269: 10112-10118.
29. Liefeldt L et al. Regulation of the endothelin system in transgenic rats expressing the human endothelin-2 gene. J Cardiol Pharmacol 1995; 26 (Suppl 3): S32-S33.
30. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 1984; 26: 137-143.
31. Hocher B et al. Characterization of the renal phenotype of transgenic rats expressing the human endothelin-2 gene. Hypertension 1996; 28: 196-201.
32. Clavell AL, Burnett JC Jr. Physiologic and pathophysiologic role of endothelin in the kidney. Curr Opin Nephrol. Hypertens. 1994; 3: 66-72.
33. Schlager G. Biometrical genetic analysis of blood pressure level in the genetically hypertensive mouse. Clin Exp Hypertens 1994; 16 (6): 809-824.
34. Fukamizu A et al. Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J Biol Chem 1993; 268: 11617-11621.
35. Merrill DC et al. Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invets 1996; 97: 1047-1055.
36. Schlager G. Biometrical genetic analysis of blood pressure level in the genetically hypertensive mouse. Clin Exp Hypertens 1994; 16 (6): 809-824.